i
Loading Page
loading, please wait

Select Year:

Home > TX Providers
provider's profile picture

Dr. David F. Mobley, MD, FACS

Accepting New Patients
Specializes in: Urologic Oncology
Professional interests include: kidney problems, endourologic procedures, testicular cancer, and more.
18300 KATY FREEWAY SUITE 325
HOUSTON, TX 77094

Dr. David F. Mobley, MD, FACS is an urologic oncologist in HOUSTON, TX specializing in urologic oncology. Dr. David F. Mobley, MD, FACS is affiliated with Houston Methodist Hospital, Houston Methodist West Hospital, Houston Methodist and Houston Methodist Urology Associates.

View Doctor's Full Profile (832) 522-8300

Office Locations

18300 KATY FREEWAY SUITE 325
HOUSTON, TX 77094
open_in_new

Some issues Dr. David F. Mobley, MD, FACS can help you with:

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

  • Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
  • Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
  • Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

Urinary Tract Infection (UTI)

A urinary tract infection, or UTI, happens when bacteria enter the body through the opening where urine is normally released. The bacteria infect the lining of the urethra and bladder, turning them red and inflamed. This causes pain in the abdomen or pelvic area, a burning sensation during urination, a sense of urgency about going to the bathroom, frequent urination, and urine that smells bad and looks cloudy, or even contains traces of blood. If the urinary tract infection is severe, it may travel all the way to the kidneys, a more serious kind of UTI called pyelonephritis. Patients with this kidney infection might have blood in their urine, feel back pain, and develop a fever.

Urinary tract infections are extremely common: 12% of all men and 40-50% of all women will have a urinary tract infection during their lifetime. They are more common in women because women have shorter urethras, so bacteria have a shorter distance to travel from the outside of the body to the bladder and cause an infection. Some people also have urethras that are an unusual shape or have an obstruction in the urethra that makes getting a UTI more likely. Also, certain chronic illnesses like diabetes weaken the immune system, so any bacteria in the body are more likely to cause an infection.

A urinary tract infection can be diagnosed very quickly by a doctor. A sample of urine can be examined under a microscope for the presence of bacteria or white blood cells. There are also diagnostic strips that can be used to test a urine sample without the need for a microscope. Once a diagnosis is made, treatment is a course of oral antibiotics, and most patients feel better within just a few days. There are some things that patients can do themselves to help reduce the risk of getting a urinary tract infection in the future. Stay well hydrated, wipe from front to back after going to the bathroom, wear breathable cotton undergarments, and don't hold it in when patients feel the urge to go.

In The News 

“Dr. David Mobley of Houston Methodist Hospital addresses business leaders at the annual corporate kick-off luncheon of the Alzheimer's Association at Perry's Steakhouse, 9827 Katy Freeway in...”—"Alzheimer's Association kick off photo", Katy Times, June 2025

Noteworthy Medicare Patient Procedures Performed by Dr. David F. Mobley, MD, FACS in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 25%

By Volume:

post void residual study

In 2012, Dr. David F. Mobley, MD, FACS performed more post void residual study procedures for Medicare patients than 75% of providers in related specialties within Texas.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2012 were lab tests, urologic procedures, hormone therapy and injections.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

catheterization 16
diagnostic procedures 25
doctor visit 1171
hormone therapy 168
injections 168
lab tests 308
minimally invasive procedures 58
minor procedures 25
urologic procedures 220

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2013 were lab tests, urologic procedures, hormone therapy and injections.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 20
anorectal procedures 12
diagnostic procedures 32
doctor visit 1182
hormone therapy 209
injections 194
lab tests 321
laser treatment 20
minimally invasive procedures 75
minor procedures 20
urologic procedures 284

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 603
Female 112
Ethnicity
Non-Hispanic White 636
Black 16
Hispanic 41
Asian 0
Other 0
Native American 0
Age
From 65 to 74 316
From 75 to 84 287
85 and over 90
Less than 65 22

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2013

Hypertension 63
High Cholesterol 58
Stroke 6
Ischemic Heart Disease 41
Depression 11
Chronic Kidney Disease 15
Asthma 5
Osteoperosis 5
Atrial Fibrilation 14
Heart Failure 16
Chronic Obstructive Pulmonary Disease 9
Diabetes 25
Dementia 8
Cancer 17

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2014 were lab tests, urologic procedures, minimally invasive procedures and catheterization.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 22
catheterization 52
diagnostic procedures 28
doctor visit 1178
hormone therapy 25
lab tests 561
laser treatment 22
minimally invasive procedures 96
minor procedures 28
urologic procedures 427

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 578
Female 121
Ethnicity
Non-Hispanic White 621
Black 21
Hispanic 32
Asian 0
Other 12
Native American 0
Age
From 65 to 74 338
From 75 to 84 254
85 and over 82
Less than 65 25

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2014

Hypertension 61
High Cholesterol 54
Stroke 5
Ischemic Heart Disease 39
Depression 8
Chronic Kidney Disease 16
Asthma 5
Osteoperosis 5
Atrial Fibrilation 14
Heart Failure 15
Chronic Obstructive Pulmonary Disease 7
Diabetes 28
Dementia 6
Cancer 14

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2015 were lab tests, urologic procedures, minimally invasive procedures and catheterization.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 16
anorectal procedures 17
catheterization 38
diagnostic procedures 17
doctor visit 1214
lab tests 482
laser treatment 16
minimally invasive procedures 77
potassium test 13
urologic procedures 425

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 1260
Female 242
Ethnicity
Non-Hispanic White 1320
Black 42
Hispanic 74
Asian 0
Other 38
Native American 0
Age
From 65 to 74 742
From 75 to 84 548
85 and over 172
Less than 65 40

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2015

Hypertension 62
High Cholesterol 57
Stroke 6
Ischemic Heart Disease 39
Depression 10
Chronic Kidney Disease 22
Asthma 8
Osteoperosis 4
Atrial Fibrilation 14
Heart Failure 15
Chronic Obstructive Pulmonary Disease 8
Diabetes 28
Dementia 9
Cancer 15

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2016 were lab tests, urologic procedures, minimally invasive procedures and potassium test.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 11
catheterization 17
diagnostic procedures 16
doctor visit 1270
hormone therapy 16
lab tests 453
laser treatment 11
minimally invasive procedures 77
minor procedures 16
potassium test 21
urologic procedures 325

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 654
Female 148
Ethnicity
Non-Hispanic White 698
Black 26
Hispanic 38
Asian 17
Other 23
Native American 0
Age
From 65 to 74 398
From 75 to 84 286
85 and over 98
Less than 65 20

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2016

Hypertension 64
High Cholesterol 52
Stroke 4
Ischemic Heart Disease 38
Depression 12
Chronic Kidney Disease 26
Asthma 10
Osteoperosis 6
Atrial Fibrilation 13
Heart Failure 14
Chronic Obstructive Pulmonary Disease 7
Diabetes 27
Dementia 9
Cancer 14

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2017 were lab tests, urologic procedures, minimally invasive procedures and minor procedures.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 12
catheterization 15
diagnostic procedures 18
doctor visit 1275
lab tests 355
laser treatment 12
minimally invasive procedures 89
minor procedures 18
urologic procedures 287

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 665
Female 143
Ethnicity
Non-Hispanic White 697
Black 30
Hispanic 40
Asian 0
Other 23
Native American 0
Age
From 65 to 74 413
From 75 to 84 286
85 and over 89
Less than 65 20

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2017

Hypertension 64
High Cholesterol 47
Stroke 4
Ischemic Heart Disease 38
Depression 12
Chronic Kidney Disease 25
Asthma 6
Osteoperosis 5
Atrial Fibrilation 12
Heart Failure 14
Chronic Obstructive Pulmonary Disease 8
Diabetes 26
Dementia 9
Cancer 15

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2018 were urologic procedures, lab tests, minimally invasive procedures and minor procedures.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 18
diagnostic procedures 26
doctor visit 1147
lab tests 106
laser treatment 18
minimally invasive procedures 78
minor procedures 26
urologic procedures 227

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 661
Female 123
Ethnicity
Non-Hispanic White 680
Black 31
Hispanic 33
Asian 16
Other 24
Native American 0
Age
From 65 to 74 404
From 75 to 84 279
85 and over 87
Less than 65 14

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2018

Hypertension 64
High Cholesterol 59
Stroke 5
Ischemic Heart Disease 38
Depression 11
Chronic Kidney Disease 27
Asthma 7
Osteoperosis 5
Atrial Fibrilation 12
Heart Failure 14
Chronic Obstructive Pulmonary Disease 8
Diabetes 27
Dementia 7
Cancer 16

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2019 were urologic procedures, minimally invasive procedures, minor procedures and diagnostic procedures.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 19
diagnostic procedures 35
doctor visit 1245
hormone therapy 28
laser treatment 19
minimally invasive procedures 91
minor procedures 35
urologic procedures 303

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 702
Female 132
Ethnicity
Non-Hispanic White 727
Black 26
Hispanic 37
Asian 18
Other 26
Native American 0
Age
From 65 to 74 434
From 75 to 84 297
85 and over 86
Less than 65 17

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2019

Hypertension 65
High Cholesterol 60
Stroke 4
Ischemic Heart Disease 40
Depression 12
Chronic Kidney Disease 24
Asthma 5
Osteoperosis 5
Atrial Fibrilation 12
Heart Failure 13
Chronic Obstructive Pulmonary Disease 6
Diabetes 24
Dementia 8
Cancer 19

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2020 were urologic procedures, minimally invasive procedures, minor procedures and diagnostic procedures.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

diagnostic procedures 18
doctor visit 1099
hormone therapy 15
minimally invasive procedures 58
minor procedures 18
urologic procedures 245

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 739
Female 104
Ethnicity
Non-Hispanic White 739
Black 24
Hispanic 32
Asian 19
Other 29
Native American 0
Age
From 65 to 74 444
From 75 to 84 300
85 and over 82
Less than 65 17

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2020

Hypertension 65
High Cholesterol 61
Stroke 5
Ischemic Heart Disease 41
Depression 13
Chronic Kidney Disease 27
Asthma 5
Osteoperosis 4
Atrial Fibrilation 13
Heart Failure 13
Chronic Obstructive Pulmonary Disease 8
Diabetes 27
Dementia 7
Cancer 17

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2021 were urologic procedures, minimally invasive procedures, minor procedures and diagnostic procedures.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

diagnostic procedures 24
doctor visit 1121
minimally invasive procedures 76
minor procedures 24
urologic procedures 273

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 711
Female 101
Ethnicity
Non-Hispanic White 721
Black 0
Hispanic 30
Asian 17
Other 29
Native American 0
Age
From 65 to 74 429
From 75 to 84 292
85 and over 80
Less than 65 11

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2021

Hypertension 70
High Cholesterol 65
Stroke 5
Ischemic Heart Disease 43
Depression 13
Chronic Kidney Disease 29
Asthma 4
Osteoperosis 5
Atrial Fibrilation 13
Heart Failure 14
Chronic Obstructive Pulmonary Disease 7
Diabetes 26
Dementia 8
Cancer 17

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX during 2022 were urologic procedures, minimally invasive procedures, minor procedures and diagnostic procedures.

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

ablation 15
diagnostic procedures 27
doctor visit 1076
laser treatment 15
minimally invasive procedures 84
minor procedures 27
urologic procedures 252

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 698
Female 85
Ethnicity
Non-Hispanic White 682
Black 15
Hispanic 37
Asian 18
Other 31
Native American 0
Age
From 65 to 74 389
From 75 to 84 307
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS in 2022

Hypertension 75
High Cholesterol 75
Stroke 8
Ischemic Heart Disease 35
Depression 10
Chronic Kidney Disease 22
Asthma 6
Osteoperosis 6
Atrial Fibrilation 20
Heart Failure 11
Chronic Obstructive Pulmonary Disease 11
Diabetes 27
Dementia 5
Cancer 22

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. David F. Mobley, MD, FACS for Medicare patients.

The highest averages for the top procedures that Dr. David F. Mobley, MD, FACS treated as an urologic oncologist in HOUSTON, TX were lab tests, urologic procedures, injections and minimally invasive procedures.

ablation 16
anorectal procedures 14
catheterization 27
diagnostic procedures 24
doctor visit 1179
hormone therapy 76
injections 181
lab tests 369
laser treatment 16
minimally invasive procedures 78
minor procedures 23
potassium test 17
urologic procedures 297

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. David F. Mobley, MD, FACS.

Gender
Male 661
Female 119
Ethnicity
Black / African American 21
Asian / Pacific Islander 9
Non-Hispanic White 683
Native American / Alaskan Native 0
Hispanic 35
Other 21
Age
75 to 84 285
85 and over 78
Less than 65 16
65 to 74 391

Average of Total of Conditions of Medicare patients treated by Dr. David F. Mobley, MD, FACS From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. David F. Mobley, MD, FACS treated were hypertension, high cholesterol, ischemic heart disease and diabetes.

Hypertension 59
High Cholesterol 53
Stroke 4
Ischemic Heart Disease 35
Depression 10
Chronic Kidney Disease 21
Asthma 5
Osteoporosis 4
Heart Failure 12
Chronic Obstructive Pulmonary Disease 7
Diabetes 24
Atrial Fibrillation 12
Dementia 6
Cancer 15

Education & Training

He completed residency at Baylor College of Medicine Affiliated Hospitals. He is certified by the American Board of Urology and has a state license in Texas.

Residency: Baylor College of Medicine Affiliated Hospitals

Board Certification: American Board of Urology

Licensed In: Texas

Affiliations & Hospitals

Dr. David F. Mobley, MD, FACS is associated with these hospitals and organizations:

Houston Methodist Hospital
Houston Methodist West Hospital
Houston Methodist
Houston Methodist Urology Associates

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. David F. Mobley, MD, FACS appears to accept the following insurance providers: CIGNA Open Access, United Healthcare PPO, United Healthcare POS, United Healthcare HMO, United Healthcare EPO, Blue Choice PPO, Blue Choice POS, First Health PPO, Aetna POS, Aetna QPOS, Aetna Workers' Compensation, Golden Rule, TRICARE, Best Doctors, Aetna Select, Aetna EPO, Trustmark , Aetna PPO, Aetna HMO, CIGNA Network, Aetna Affordable Health Choices, Aetna Signature Administrators, CIGNA PPO, CIGNA POS, CIGNA HMO, Aetna Medicare PPO, CIGNA EPO, CIGNA Choice Fund, CIGNA Indemnity, AARP, Medicare Advantage, Blue Cross Blue Shield HMO, Blue Cross Blue Shield POS, Blue Cross Blue Shield EPO, Three Rivers Provider Network, Coventry PPO, HealthSpring, US Family Health Plan, Blue Cross Blue Shield PPO, United Healthcare, Medicare, Railroad Medicare, Humana, Cigna, Molina Healthcare, WellPoint, Aetna Open Access, United Healthcare Community Plan (AmeriChoice), Humana Medicare Advantage PPO, Horizon Blue Cross Blue Shield, CIGNA Network Open Access, PHCS PPO, MultiPlan PPO, Private Healthcare Systems (PHCS), Aetna APCN Plus Multi-Tier HM Tier 2, GeoBlue, BCBS PPO GUIDESTONE, TRS-Care Standard ALT B II Group 485006, TRS-Care Standard ALT B I Group 485005, Community Health Choice PREMIER Gold, TRS-ActiveCare Fully Insured Plan-South Texas Region Group 295430, Aetna Student Health, TX Annual Conf of UMC-UMR, Kelsey Seybold Affiliate Network, TRS-Care Standard ALT A II Group 485003, Aetna Transplant, TRS-ActiveCare Primary Group 385003, DEVOTED DUAL PLUS GREATER HOUSTON, DEVOTED CORE GREATER HOUSTON HMO, TRS-Care Standard Group 485000, UnitedHealthOne, TRS-Care Standard ALT A I Group 485002, Community Health Choice PREMIER Silver, Blue Essentials Access, UMR, TRS-ActiveCare Fully Insured Plan-West Texas Region Group 295781, TRS-ActiveCare 2 Group 385002, DEVOTED EXTRA GREATER HOUSTON (HMO), HAA Preferred Partners (International), Aetna Common Spirit Minimum Value Plan, BCBS PPO Wespath, Aetna Health Network, Aetna Managed Choice / Elect Choice, United Health Integrated Services, Aetna Meritain Hlth/Aetna Premier Care (APCN), Olympus Managed Care (International), Aetna CommonSpirit Health KelseyCare, DEVOTED PREMIUM (PRIME) GREATER HOUSTON (HMO), Aetna Medicare HMO Prime, Aetna Choice POS / Open Choice, Aetna Signature Administrators Allied Benefits, Blue Edge, Blue Essentials, Aetna International, Aetna Medicare Dual Complete Plan (HMO D-SNP), Aetna TX Pref Plus II Network, Blue Cross Blue Shield FEP Federal Employee Plan, DEVOTED GIVEBACK GREATER HOUSTON (HMO), TRS-Care Standard CMED Group 485001, TRS-ActiveCare HD Group 385000, TRS-ActiveCare Primary Plus Group 385001, Aetna Signature Administrators TX Annual Conf of UMC and Aetna Premier Care Network.

Insurance Accepted by Provider includes:

According to our sources, Dr. David F. Mobley, MD, FACS accepts the following insurance providers:

CIGNA Open Access
United Healthcare PPO
United Healthcare POS
United Healthcare HMO
United Healthcare EPO
Blue Choice PPO
Blue Choice POS
First Health PPO
Aetna POS
Aetna QPOS
Aetna Workers' Compensation
Golden Rule
TRICARE
Best Doctors
Aetna Select
Aetna EPO
Trustmark
Aetna PPO
Aetna HMO
CIGNA Network
Aetna Affordable Health Choices
Aetna Signature Administrators
CIGNA PPO
CIGNA POS
CIGNA HMO
Aetna Medicare PPO
CIGNA EPO
CIGNA Choice Fund
CIGNA Indemnity
AARP
Medicare Advantage
Blue Cross Blue Shield HMO
Blue Cross Blue Shield POS
Blue Cross Blue Shield EPO
Three Rivers Provider Network
Coventry PPO
HealthSpring
US Family Health Plan
Blue Cross Blue Shield PPO
United Healthcare
Medicare
Railroad Medicare
Humana
Cigna
Molina Healthcare
WellPoint
Aetna Open Access
United Healthcare Community Plan (AmeriChoice)
Humana Medicare Advantage PPO
Horizon Blue Cross Blue Shield
CIGNA Network Open Access
PHCS PPO
MultiPlan PPO
Private Healthcare Systems (PHCS)
Aetna APCN Plus Multi-Tier HM Tier 2
GeoBlue
BCBS PPO GUIDESTONE
TRS-Care Standard ALT B II Group 485006
TRS-Care Standard ALT B I Group 485005
Community Health Choice PREMIER Gold
TRS-ActiveCare Fully Insured Plan-South Texas Region Group 295430
Aetna Student Health
TX Annual Conf of UMC-UMR
Kelsey Seybold Affiliate Network
TRS-Care Standard ALT A II Group 485003
Aetna Transplant
TRS-ActiveCare Primary Group 385003
DEVOTED DUAL PLUS GREATER HOUSTON
DEVOTED CORE GREATER HOUSTON HMO
TRS-Care Standard Group 485000
UnitedHealthOne
TRS-Care Standard ALT A I Group 485002
Community Health Choice PREMIER Silver
Blue Essentials Access
UMR
TRS-ActiveCare Fully Insured Plan-West Texas Region Group 295781
TRS-ActiveCare 2 Group 385002
DEVOTED EXTRA GREATER HOUSTON (HMO)
HAA Preferred Partners (International)
Aetna Common Spirit Minimum Value Plan
BCBS PPO Wespath
Aetna Health Network
Aetna Managed Choice / Elect Choice
United Health Integrated Services
Aetna Meritain Hlth/Aetna Premier Care (APCN)
Olympus Managed Care (International)
Aetna CommonSpirit Health KelseyCare
DEVOTED PREMIUM (PRIME) GREATER HOUSTON (HMO)
Aetna Medicare HMO Prime
Aetna Choice POS / Open Choice
Aetna Signature Administrators Allied Benefits
Blue Edge
Blue Essentials
Aetna International
Aetna Medicare Dual Complete Plan (HMO D-SNP)
Aetna TX Pref Plus II Network
Blue Cross Blue Shield FEP Federal Employee Plan
DEVOTED GIVEBACK GREATER HOUSTON (HMO)
TRS-Care Standard CMED Group 485001
TRS-ActiveCare HD Group 385000
TRS-ActiveCare Primary Plus Group 385001
Aetna Signature Administrators TX Annual Conf of UMC
Aetna Premier Care Network

Ratings & Reviews

Dr. David F. Mobley, MD, FACS has an exceptional overall rating with an average of 4.96 out of 5 stars based on 232 ratings. We collect ratings and reviews of Dr. David F. Mobley, MD, FACS from all over the web to help you find the right in HOUSTON, TX. 

4.96
Overall Rating
Leave a Review
Reviews From Around The Web
Overall Rating: 5.0 2025-10-28
Patient verified via Press Ganey
Dr. Mobley is excellent! I had been receiving care for elevated PSA from another facility for over ten years. Dr. Mobley was the first to explain possible causes for me condition and options. After six months on finastiride my PSA dropped from 7+ to 3.00!
Overall Rating: 5.0 2025-12-23
Patient verified via Press Ganey
These positive grades apply to virtually all of my visits with Dr. Mobely in the past. He's an all-around excellent doctor.
Overall Rating: 5.0 2025-02-20
Patient verified via Press Ganey
I came to Dr Mobley's because I listened to his radio broadcast and believe he is very knowledgeable in this field.
Overall Rating: 5.0 2026-03-03
Patient verified via Press Ganey
Dr Mobley and his assistant Julie were really understanding, listened to all my concerns with oatience
Overall Rating: 5.0 2025-08-06
Patient verified via Press Ganey
Dr Mobley was very helpful in responses to my questions. He was attentive and communicated well.
Overall Rating: 5.0 2024-11-09
Patient verified via Press Ganey
Have been with Dr. Mobley for many years and he has always listened and answered my questions.
Overall Rating: 5.0 2026-02-19
Patient verified via Press Ganey
I've been seeing Dr. Mobley for around 30 years. He and his staff have always been great.
Overall Rating: 5.0 2025-03-19
Patient verified via Press Ganey
Dr. Mobley is thorough and listens to his patients.
Overall Rating: 5.0 2025-12-20
Patient verified via Press Ganey
Dr. Mobley is a doctor's doctor. Clone this man.
Overall Rating: 5.0 2024-10-29
Patient verified via Press Ganey
Would recommend to any family member or friends

To see all 232 reviews for Dr. David F. Mobley, MD, FACS, view their full profile.

General Payments

These charts describe general payments received by Dr. David F. Mobley, MD, FACS. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
Astellas Pharma US Inc $61,320 Myrbetriq
$51,674 		Mirabegron
$1,737 		Vesicare
$924 		XTANDI
$585
$6,400
EDAP TECHNOMED INC $9,758
$9,758
Medivation Inc. $5,707 XTANDI
$82
$5,625
Boston Scientific Corporation $3,283 BPH
$939 		AMS
$892 		GENERAL BPH
$249 		AMS 700
$148 		TACTRA
$141 		Other
$914
Pfizer Inc. $2,202 XTANDI
$1,596 		VIAGRA
$173 		TOVIAZ
$153 		PAXLOVID
$144 		ORGOVYX
$132 		Other
$4
Other $13,019 GreenLight Laser Therapy
$1,259 		Penumbra System
$706 		ALTIS
$654 		Aveed
$615 		BOTOX
$526 		Other
$9,258
Types of Payments
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $54,115
Food and Beverage $19,215
Consulting Fee $11,875
Travel and Lodging $9,049
Education $1,037

Research Payments

Dr. David F. Mobley, MD, FACS has received 26 research payments totaling $155,796.

Biography

Dr. David Mobley is a specialist in urologic oncology. Patients rated him highly, giving him an average of 5.0 stars (out of 5). Dr. Mobley's areas of expertise include the following: bladder cancer, erectile dysfunction (impotence), and endourologic procedures. His professional affiliations include Houston Methodist Hospital and Houston Methodist West Hospital. He is an in-network provider for several insurance carriers, including Trustmark, Aetna EPO, and Blue California. Doctor.com reports that he is accepting new patients at his office in HOUSTON, TX. Dr. Mobley is a graduate of the University of Tennessee Health Science Center College of Medicine. Dr. Mobley trained at a hospital affiliated with Baylor College of Medicine for residency. He speaks Spanish.

Other Providers in HOUSTON, TX